 |
市場調査レポート
商品コード
1454158
バーチャル臨床試験の世界市場規模、シェア、成長分析、適応症別、試験デザイン別-産業予測、2024～2031年Global Virtual Clinical Trials Market Size, Share, Growth Analysis, By Indication(Oncology, Cardiovascular), By Study Design(Interventional, Observational) - Industry Forecast 2024-2031 |
||||||
| バーチャル臨床試験の世界市場規模、シェア、成長分析、適応症別、試験デザイン別-産業予測、2024～2031年 |
|
出版日: 2024年03月10日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
バーチャル臨床試験の世界市場規模は2022年に82億4,000万米ドルと評価され、予測期間（2024～2031年）のCAGRは5.75%で、2023年の87億1,000万米ドルから2031年には136億3,000万米ドルに成長する展望です。
世界的にデジタル医療インフラの導入が進んでいることが市場成長の主要要因です。皮膚科試験におけるバーチャル臨床試験（VCT）の利用拡大が、市場拡大をさらに後押ししています。遠隔臨床試験は、複雑な試験を必要としない皮膚疾患の評価に一般的に採用されています。コロナウイルス感染症（COVID-19）の世界の蔓延が続く中、安全で効果的なデータ収集を確実にするために、バーチャルと遠隔試験ソリューションに対する需要が顕著に急増しています。さらに、バーチャル患者対話プラットフォームの採用やウェアラブル技術の統合などの技術的進歩が成長の触媒となっています。遠隔医療プラットフォームを通じて促進されるこれらの技術は、患者と医療プロバイダーをつなぐ助けとなります。しかし、ガイドラインがなく、流入する情報を管理する必要があることが、市場成長の妨げになる可能性があります。
目次
エグゼクティブサマリー
- 市場概要
- 繁栄と衰退
調査手法
- 情報調達
- セカンダリとプライマリデータソース
- 市場規模の推定
- 市場の前提条件と制限
親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主要市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主要投資の分析
- 主要成功要因
- 競合の程度
市場力学と展望
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
バーチャル臨床試験の世界市場：適応症別
- 市場概要
- 腫瘍学
- 心臓血管
- その他
バーチャル臨床試験の世界市場：試験デザイン別
- 市場概要
- 介入的
- 観察的
- 拡張アクセス
バーチャル臨床試験の世界市場規模：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州地域
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
- ラテンアメリカ
- ブラジル
- その他のラテンアメリカ地域
- 中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主要市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- IQVIA Holdings Inc.
- Covance Inc.（LabCorpの子会社）
- PRA Health Sciences Inc.
- Medidata Solutions Inc.（Dassault Systemesの子会社）
- Parexel International Corporation（Pamplona Capital Managementの子会社）
- Oracle Corporation
- Clinipace Worldwide
- Medable Inc.
- THREAD Research Inc.
- Science 37 Inc.
- Veeva Systems Inc.
- Florence Healthcare
- Clinerion Ltd.
- Evidation Health Inc.
- Transparency Life Sciences
- Reify Health Inc.
- Illingworth Research Group Ltd.
- Circuit Clinical Inc.
- Antidote Technologies Inc.
- Aktana Inc.
Global Virtual Clinical Trials Market size was valued at USD 8.24 billion in 2022 and is poised to grow from USD 8.71 billion in 2023 to USD 13.63 billion by 2031, growing at a CAGR of 5.75% during the forecast period (2024- 2031).
The increasing adoption of digital healthcare infrastructure globally is a key driver of market growth. The expanded utilization of virtual clinical trials (VCT) for dermatology testing is further fueling market expansion. Remote trials are commonly employed to assess skin conditions that do not necessitate complex examinations. With the ongoing spread of the coronavirus disease (COVID-19) worldwide, there has been a notable surge in demand for virtual and remote testing solutions to ensure safe and effective data collection. Additionally, technological advancements such as the introduction of virtual patient interaction platforms and the integration of wearable technologies are serving as catalysts for growth. These technologies, facilitated through telemedicine platforms, aid in connecting patients with healthcare providers. However, the absence of guidelines and the need to manage the influx of information may hinder market growth.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Virtual Clinical Trials Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Virtual Clinical Trials Market Segmental Analysis
Global virtual clinical trials market is segmented on the basis of indication, study design, and region. By indication, global market is segmented into oncology, cardiovascular and other. By study design, global market is segmented into, Interventional, observational and expanded access. By region, global market is divided into North America, Europe, Asia Pacific, Latin America, and MEA.
Drivers of the Global Virtual Clinical Trials Market
Real-time reporting and data collection are significant factors driving market growth. A notable shift involves the direct transfer of data from smartphones or wearables into the clinical database, eliminating the need for clinical trial staff to manually input data from different documents, which may result in potential data loss or editing errors. This streamlined process enhances data accuracy and integrity. Additionally, involving a diverse range of participants contributes to richer and higher-quality data.
Restraints in the Global Virtual Clinical Trials Market
Data security is a significant concern that impedes the growth of the global virtual clinical trials market. Patients' confidential medical data is transmitted directly over the Internet, making it vulnerable to hacking or unauthorized access. Sponsors are required to inform all participants of this potential risk in the informed consent form. In the event of a data breach, there must be a clear plan in place to address the issue and notify participants and trial sponsors promptly.
Market Trends of the Global Virtual Clinical Trials Market
A virtual clinical trial offers an alternative approach to traditional clinical trials, leveraging new connected devices to enhance clinical data collection, analysis, and interpretation. Various digital tools such as clinical trial monitoring devices, clinical trial software, eCOA, ePRO, and eConsent are employed to facilitate clinical trial activities. The "bring-your-own-devices" strategy, widely embraced by CROs and sponsors, enables participants to utilize their Internet-enabled solutions to provide the necessary data. Technological advancements and increased confidence in research outcomes are driving the exploration of new solutions. A recent retrospective approach utilizing synthetic clinical trials has emerged as a significant development in the virtual clinical trials market, expected to experience substantial growth. Additionally, the integration of artificial intelligence (AI) in clinical trials is transforming the trial process by accelerating target validation, clinical trial design, and patient identification for participation in virtual clinical trials.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global Virtual Clinical Trials Market by Indication
- Market Overview
- Oncology
- Cardiovascular
- other
Global Virtual Clinical Trials Market by Study Design
- Market Overview
- Interventional
- Observational
- Expanded access
Global Virtual Clinical Trials Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- IQVIA Holdings Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Covance Inc. (a subsidiary of LabCorp)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PRA Health Sciences Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medidata Solutions Inc. (a subsidiary of Dassault SystA¨mes)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Parexel International Corporation (a subsidiary of Pamplona Capital Management)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Oracle Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Clinipace Worldwide
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medable Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- THREAD Research Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Science 37 Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Veeva Systems Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Florence Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Clinerion Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Evidation Health Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Transparency Life Sciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Reify Health Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Illingworth Research Group Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Circuit Clinical Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Antidote Technologies Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Aktana Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
